Tarsus Pharmaceuticals, Inc. TARS Common Stock, Capital Shares Reserved for Future Issuance, Effect Of Restricted Stock Units Available For Future Grant
Common Stock, Capital Shares Reserved for Future Issuance, Effect Of Restricted Stock Units Available For Future Grant at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept tars:CommonStockCapitalSharesReservedForFutureIssuanceEffectOfRestrictedStockUnitsAvailableForFutureGrant.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s common stock, capital shares reserved for future issuance, effect of restricted stock units available for future grant.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s common stock, capital shares reserved for future issuance, effect of restricted stock units available for future grant?
- Tarsus Pharmaceuticals, Inc. (TARS) reported common stock, capital shares reserved for future issuance, effect of restricted stock units available for future grant of 1.7M in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s common stock, capital shares reserved for future issuance, effect of restricted stock units available for future grant changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s common stock, capital shares reserved for future issuance, effect of restricted stock units available for future grant decreased by 12.2% year-over-year, from 1.9M to 1.7M.
- What does common stock, capital shares reserved for future issuance, effect of restricted stock units available for future grant mean?
- This represents the pool of common shares reserved for future grants of Restricted Stock Units (RSUs). It provides visibility into the company's future equity compensation pipeline and potential dilution from upcoming awards. Investors use this to estimate the impact of future stock-based compensation on earnings per share.